Status:
COMPLETED
Epidemiology of Congenital Heart Disease in France
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
National Reference Center for Complex Congenital Heart Disease, Marie-Lannelongue Medical and Surgical Center, Le Plessis Robinson
University Hospital, Bordeaux
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
Brief Summary
Congenital heart disease (CHD) is the leading cause of birth defects, with an incidence of 0.8%. Since the 1980s, France has been a pioneer in neonatal CHD surgery (Pr. Fontan, Pr. Lecomte, Pr. Serraf...
Detailed Description
Retrospective epidemiological study based on the national health insurance hospital database from 2010 to 2020 (10 years): Main objective: • To assess the prevalence of patients with CHD hospitalize...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Patient (of any age) with a CHD as defined by the international ACC-CHD classification and listed in the ICD10 classification, hospitalized from 01/01/2010 to 12/31/2019 in a French tertiary care hospital from the M3C network.
- Exclusion criteria:
- \- Patient with non-malformative genetic heart disease (cardiomyopathy, hereditary rhythmic disease).
Exclusion
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
450000 Patients enrolled
Trial Details
Trial ID
NCT04740177
Start Date
February 1 2020
End Date
December 30 2020
Last Update
March 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295